Age related seroprevalence of antibodies to varicella in India.

dc.contributor.authorLokeshwar, M Ren_US
dc.contributor.authorAgrawal, Aen_US
dc.contributor.authorSubbarao, S Den_US
dc.contributor.authorChakraborty, M Sen_US
dc.contributor.authorRam Prasad, A Ven_US
dc.contributor.authorWeil, Jen_US
dc.contributor.authorBock, H Len_US
dc.contributor.authorKanwal, Sen_US
dc.contributor.authorShah, R Cen_US
dc.contributor.authorShah, Nen_US
dc.date.accessioned2000-07-25en_US
dc.date.accessioned2009-05-27T04:56:30Z
dc.date.available2000-07-25en_US
dc.date.available2009-05-27T04:56:30Z
dc.date.issued2000-07-25en_US
dc.description.abstractOBJECTIVE: To determine the age related prevalence of Varicella Zoster Virus (VZV) antibodies in India. SETTING: This was a cross sectional multicentric study performed in 4 major cities of India: Calcutta (outpatients), Mumbai (outpatients), Lucknow (walk-in patients to a diagnostic laboratory, orphanage and factory workers) and Bangalore (outpatients and walk-in patients to a diagnostic laboratory). METHODS: A total of 1609 volunteers from birth to 40 years of age were included into the study. IgG antibodies against VZV were determined using commercial kits (ELISA-Enzygnost). RESULTS: Overall seroprevalence of anti VZV antibodies was 68. 22percnt. The age related seroprevalence rate of anti VZV antibodies was 29percnt in the age group of 1-5 years, 51.1percnt in 5-10 years, 71.7percnt in 11-15 years, 79.8percnt in 16-20 years, 88.1percnt in 21-30 years and 91.1percnt in 31-40 years. CONCLUSION: A significant proportion of adolescents and adults are susceptible to varicella in India, as in other tropical countriesen_US
dc.description.affiliationHinduja Hospital, Mumbai, India.en_US
dc.identifier.citationLokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N. Age related seroprevalence of antibodies to varicella in India. Indian Pediatrics. 2000 Jul; 37(7): 714-9en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/6631
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAge Distributionen_US
dc.subject.meshChickenpox --epidemiologyen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshCross-Sectional Studiesen_US
dc.subject.meshHerpesvirus 3, Human --immunologyen_US
dc.subject.meshHumansen_US
dc.subject.meshIndia --epidemiologyen_US
dc.subject.meshInfanten_US
dc.subject.meshInfant, Newbornen_US
dc.subject.meshSeroepidemiologic Studiesen_US
dc.titleAge related seroprevalence of antibodies to varicella in India.en_US
dc.typeJournal Articleen_US
dc.typeResearch Support, Non-U.S. Gov'ten_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: